"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"

Starts 1:45pm on Friday, October 12th 2012
Ends 2:45pm on Friday, October 12th 2012
Location 670 Albany Street Room #107/108
URL http://www.bumc.bu.edu/busm-pathology/files/2008/09/Seminar-Fall-2012.pdf
Contact Name Deb Kiley
Contact Email debra.kiley@bmc.org
Contact Phone 617 414 7914
Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD Director of Developmental Therapeutics Massachusetts General Hospital Cancer Center Harvard Medical School
Primary teaching affiliate
of BU School of Medicine